Telekast-L Tablet

Telekast-L Tablet is a combination medicine prescribed to treat allergies. It contains two ingredients: levocetirizine and montelukast. It relieves symptoms such as runny nose, sneezing, breathing difficulty, itchy skin and congestion. Your doctor may prescribe this medication for conditions such as hay fever/rhinitis, seasonal allergies, asthma, exercise-induced bronchospasm, urticaria, eczema and food allergy.

Telekast-L Tablet should be taken as advised by your doctor. It is best to take them as a whole before or after food. Depending on the severity of your allergy, your doctor might adjust the doses. Take them until your allergic symptoms disappear entirely, and follow your prescription for the best results.

The common side effects of Telekast-L Tablet include drowsiness, dizziness, headache, fatigue, nausea, stomach pain, vomiting and dry mouth. They typically last for a short period and usually go away on their own. Contact your healthcare provider if the problems persist.

Telekast-L Tablet is contraindicated for people who are hypersensitive to montelukast, hydroxyzine or cetirizine. Always let your doctor know of any health conditions you might have. Generally, this combination drug is considered safe for most people.

Telekast-L Tablet is an allergy medicine used to treat hay fever/rhinitis, seasonal allergies, bronchial asthma, exercise-induced bronchospasm, urticaria, eczema and food allergy. It alleviates symptoms in patients with allergies such as runny nose, sneezing, breathing difficulty, itchy skin and congestion.

The main ingredients of this medication are levocetirizine and montelukast. Levocetirizine is a low-sedating, long-acting H1-receptor antagonist that makes allergy symptoms like sneezing and watery eyes disappear. Montelukast is a leukotriene receptor antagonist, and it helps by opening up the airways so breathing becomes easier.

Telekast-L Tablet significantly reduces the allergic response and removes breathing difficulties (in patients with asthma), allowing people to carry on with their daily physical activities. It also helps the appearance by ridding the skin of any rashes or spots. Depending on your symptoms, you may take the medication, and it usually doesn’t present with many notable adverse effects.

Telekast-L Tablet contains two ingredients: levocetirizine and montelukast. Both work together to suppress the allergic reactions that allergens trigger by inhibiting certain chemicals in our bodies.

Montelukast, an anti-inflammatory agent, creates its therapeutic effect by selectively blocking leukotrienes. Leukotrienes are chemicals that cause inflammation, tightening of airways and excess production of mucus. The body releases this inflammatory mediator when an allergen enters the body. Thus, montelukast makes breathing easy in patients with asthma or allergy attacks.

These allergy attacks often start after exposure to allergens. To counter the potential allergy, the immune system releases an antibody called Immunoglobulin E. It then joins with allergens and activates white blood cells called mast cells. This activation results in the release of chemicals, including leukotrienes, prostaglandins and histamines.

Telekast-L Tablet also contains levocetirizine, a low-sedating, long-acting H1-receptor antagonist. It is an antihistamine, which, as the name suggests, works against histamines. This chemical is responsible for most of the allergic responses such as coughing, sneezing, vomiting and runny nose, which are means of getting rid of this allergen from the body.

People with severe allergies experience these symptoms due to the exaggerated function of these histamines. The histamines work by binding with the H1 receptors in our body. That is why levocetirizine is prescribed for people with allergies and allergic asthma because it competitively inhibits the interaction of histamine with its H1 receptors.

• Treatments for Seasonal Allergic Rhinitis (effectivehealthcare.ahrq.gov)
• Montelukast: a brief overview (ncbi.nlm.nih.gov)
• Levocetirizine: a compound summary (pubchem.ncbi.nlm.nih.gov)